| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 3 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | EPO (European Patent Office) | 2 | |
| #4 | Australia | 1 | |
| #5 | Brazil | 1 | |
| #6 | Canada | 1 | |
| #7 | Israel | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Mexico | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Mermelstein Fred | 9 |
| #2 | Moshman Michael | 7 |
| #3 | Albin Randi | 5 |
| #4 | Mermelstein Fred H | 3 |
| #5 | Penkler Lawrence John | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP1720532A1 | Controlled release formulations | |
| US2004059003A1 | NMDA receptor antagonist formulation with reduced neurotoxicity |